Insulin resistance, type 2 diabetes, and AD: Cerebrovascular disease or neurodegeneration?

Neurology

Volumn 75, Issue 9, 2010, Pages 758-759

  Luchsinger, José A ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b Department of Epidemiology Joseph P Mailman School of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE;

ALZHEIMER DISEASE; CALORIC INTAKE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; EDITORIAL; EXERCISE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, TYPE 2; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES;

EID: 77956373209     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181eee287     Document Type: Editorial

References (9)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet 2007. Available at: http://www.cdc.gov/media/pressrel/2008/r080624.htm.
2. Matsuzaki T, Sasaki K, Tanizaki Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama Study. Neurology 2010;75:764-770.
3. Luchsinger JA. Type 2 diabetes and related conditions in relation to dementia: an opportunity for prevention? J Alz-heimers Dis 2010;20:723-736.
4. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007;4:147-152.
5. Arvanitakis Z, Schneider JA, Wilson RS, et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 2006;67:1960-1965.
6. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002;51:1256-1262.
7. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsu-linemia and risk of Alzheimer disease. Neurology 2004;63: 1187-1192.
8. Jack CR Jr, Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009;132:1355-1365.
9. Rabiner EA, Tzimopoulou S, Cunningham VJ, et al. Effects of 12 months of treatment with the PPARy agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: an 18F-FDG PET study. Alzheimer Dement 2009;5:207.